REQUEST A DEMO
Total
USD $0.00
Search more companies

Namyang Pharm Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Namyang Pharm Co.,Ltd. Profile Updated: October 23, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Namyang Pharm Co.,Ltd. is an enterprise in South Korea, with the main office in Yangpyeong County. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on July 01, 1990. There are currently 85 (2023) people employed by Namyang Pharm Co.,Ltd.. There was a net sales revenue increase of 6.63% reported in Namyang Pharm Co.,Ltd.’s latest financial highlights for 2022. Its’ total assets recorded a growth of 13.31%. The enterprise’s net profit margin decreased by 0.05% in 2022.

Headquarters
22, Yangpyeong-ro 30-gil Yeongdeungpo-gu Seoul
Yangpyeong County; Gyeonggi;

Contact Details: Purchase the Namyang Pharm Co.,Ltd. report to view the information.

Website: http://www.nypharm.co.kr

Basic Information
Total Employees:
Purchase the Namyang Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Namyang Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Namyang Pharm Co.,Ltd. report to view the information.
Incorporation Date:
July 01, 1990
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Subsidiaries
C & N Medical Inc.
Tree Medical Co.,Ltd.
Company Performance
Financial values in the chart are available after Namyang Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
6.63%
Total operating revenue
6.63%
Operating profit (EBIT)
21.61%
EBITDA
21.92%
Net Profit (Loss) for the Period
1.97%
Total assets
13.31%
Total equity
3.66%
Operating Profit Margin (ROS)
0.15%
Net Profit Margin
-0.05%
Return on Equity (ROE)
-0.16%
Debt to Equity Ratio
4.09%
Quick Ratio
-0.01%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?